Some nights I sit beside my mum’s bed and look back on the four years since her myeloma diagnosis. I find it hard to…

U.S. authorities have granted a permanent billing code for Blenrep (belantamab mafodotin), an approved treatment for certain adults with hard-to-treat multiple myeloma., a…

A $16 million research initiative is bringing together scientists from six U.S. cancer centers to build on recent breakthroughs in targeted therapies and develop longer-lasting…